Skip to main content

Day: March 17, 2026

Duke Robotics Announces New Purchase Order from Israel Electric Corporation for IC Drone, Expected to Generate Over a Million US Dollars in Revenue in 2026

New purchase order significantly expands scope of drone-enabled infrastructure maintenance services expected to approximately double prior engagement Fort Lauderdale, FL, March 17, 2026 (GLOBE NEWSWIRE) — Duke Robotics Corp. (OTCQB: DUKRD) (“Duke Robotics” or the “Company”), a leader in advanced robotics and drone-based solutions for civilian and defense markets, today announced that it has received a new purchase order from the Israel Electric Corporation (“IEC”), Israel’s governmental and largest electricity supplier, expanding the scope of the Insulator Cleaning Drone System (IC Drone) services provided by the Company for the cleaning and maintenance of high-voltage transmission infrastructure. The new order extends the existing agreement between the Company and the IEC for an additional year and increases the scale of services...

Continue reading

Financial reports Q4/2025 of eQ Community Properties and eQ Commercial Properties funds have been published

Press release17 March 2026 at 2:30 PM eQ introduced a significant upgrade to the financial reporting of its real estate funds, eQ Community Properties and eQ Commercial Properties, in November 2025. One of the largest real estate fund managers in Finland, eQ reports on its funds in a manner largely comparable to listed real estate companies. Q4/2025 financial reports are enclosed to this release in PDF-format. Currently, listed companies are subject to extensive, regulation-driven financial reporting requirements, whereas fund reporting standards are considerably more limited. With the release of the real estate funds’ financial reviews, eQ is substantially expanding and deepening its reporting practices. Going forward, eQ will publish these reviews quarterly on the funds’ websites, also where the publication schedule for 2026 can be found. eQ’s...

Continue reading

Quantum Cyber Aligns Strategy With Trump Administration’s National Cyber Security Framework, Targets Acquisitions in Quantum and Cyber Defense Sectors

Company Evaluates Multiple Strategic Acquisition Opportunities in Quantum and Cyber Security; Shareholder David Lazar Pre-Funds Additional Tranche, Bringing Total Investment to $6.0 Million BERKELEY, Calif., March 17, 2026 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ: QUCY) doing business as Quantum Cyber (the “Company” or “Quantum Cyber”), today announced a strategic update in response to the Trump Administration’s newly released National Cybersecurity Strategy, outlining the Company’s positioning within the rapidly evolving quantum and cyber defense landscape. The Company also disclosed the pre-funding of the second  tranche pursuant to a previously announced private placement with lead shareholder David Lazar. Aligning With the Trump Administration’s National Cybersecurity Strategy On March 10, 2026, the White House released...

Continue reading

Duos Edge AI and Seimitsu Partner to Strengthen Digital Infrastructure Across Georgia

Fiber integration supports deployment of modular AI infrastructure, delivering low-latency performance and high-bandwidth connectivity to customers statewide JACKSONVILLE, Fla., March 17, 2026 (GLOBE NEWSWIRE) — Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), through its operating subsidiaries including Duos Edge AI, Inc., a leader in localized edge computing solutions, announced a strategic partnership with Seimitsu, a premier fiber-based network service provider, aimed at revolutionizing digital infrastructure throughout the state of Georgia. By combining Duos Edge AI’s modular, high-performance Infrastructure Solutions with Seimitsu’s expansive high-speed fiber network, this partnership will provide businesses, municipalities, and healthcare providers with unprecedented access to low-latency processing...

Continue reading

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)

Regulatory milestone supports advancement of the SOTERIA Phase 2 basket trial evaluating PLX‑200 across multiple lysosomal storage disordersPARAMUS, NJ, March 17, 2026 (GLOBE NEWSWIRE) — Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing disease-modifying therapies for rare pediatric lysosomal storage disorders (“LSDs”), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to PLX-200 for the treatment of Late-Infantile Neuronal Ceroid Lipofuscinosis (LINCL/CLN2 disease). The Fast Track program is designed to facilitate and expedite the review of therapies intended to treat serious or life-threatening conditions with unmet medical need.  Companies receiving Fast Track designation may benefit from more frequent interactions with the FDA and...

Continue reading

LaFleur Minerals Inc. (CSE:LFLR) (OTCQB:LFLRF) (FSE:3WK0) Pairs Exploration Growth with Infrastructure in Strengthening Gold Market

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.  Disclosure: This does not represent material news, partnerships or investment advice. NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) — via MiningNewsWire — LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) today announces its placement in an editorial published by MiningNewsWire (“MNW”), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Record Gold Prices Reshape Economics of New Mine Development,” please visit: https://ibn.fm/C5mtR Gold prices have climbed to record or near-record levels in...

Continue reading

Snail, Inc. Sets Fourth Quarter and Full Year 2025 Conference Call for Thursday, March 19, 2026 at 4:30 p.m. ET

CULVER CITY, Calif., March 17, 2026 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, will hold a conference call and webcast on Thursday, March 19, 2026 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. Snail, Inc. management will host the conference call and webcast, followed by a question-and-answer period. Participants may listen to the live webcast and replay via the link here or on the Company’s investor relations website at https://investor.snail.com/. About Snail, Inc. Snail, Inc. (Nasdaq: SNAL) is a leading, global independent developer and publisher of interactive digital entertainment for consumers around...

Continue reading

One and One Green Technologies. INC Taps into Metro Manila’s Billion-Dollar E-Waste Stream, Securing Key Local Supply for Metals Recycling

San Rafael, Bulacan, Philippines, March 17, 2026 (GLOBE NEWSWIRE) — One and One Green Technologies. INC (“One and One” or the “Company”) (NASDAQ: YDDL), a Philippines-based recycler holding a government-issued license in the Philippines to import and process hazardous waste as raw materials, today announced its plan to strategically enter into the Greater Manila Area’s electronic waste (e-waste) resource recovery market. Leveraging its 1,000,000-ton-per-year hazardous waste treatment permit, the Company will source and process high-value industrial materials, including electronic sludge, copper mud, and nickel mud, from local electronics and plating manufacturers. This initiative puts One and One in a strong position to capture a significant share of the Philippines’ domestic e-waste market, which is expected to grow from...

Continue reading

PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application

FDA Grants $4.3 Million Small Business Waiver, Enabling Focus on Commercialization Preparations Company On Track to Initiate NDA Submission by the End of this Month PETACH TIKVA, Israel, March 17, 2026 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today announced that the U.S. Food and Drug Administration (FDA) has granted a small business waiver of the Prescription Drug User Fee Act (PDUFA) fee of approximately $4.3 million for the New Drug Application (NDA) for D-PLEX₁₀₀, the Company’s lead product candidate for the prevention of surgical site infections (SSIs) in abdominal colorectal surgeries. This meaningful waiver advances...

Continue reading

Rumble to Participate in the 38th Annual ROTH Conference

CEO Chris Pavlovski to Participate in Fireside Chat and 1-on-1 Investor Meetings LONGBOAT KEY, FL, March 17, 2026 (GLOBE NEWSWIRE) — Rumble Inc. (NASDAQ: RUM) (“Rumble” or the “Company”), the Freedom-First technology platform, today announced that its management team will participate in the 38th Annual ROTH Conference, to be held March 22–24, 2026, at the Ritz-Carlton Laguna Niguel in Dana Point, California. Chris Pavlovski, Chairman and Chief Executive Officer of Rumble, will participate in an analyst-selected fireside chat on Monday, March 23, 2026, at 1:00 PM PT/ 4:00 PM ET, and will conduct one-on-one meetings with institutional investors throughout the conference. To schedule a meeting with Mr. Pavlovski and the Rumble team, please contact your Roth representative or investors@rumble.com. The fireside chat will be webcast...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.